NIH Institute / Center · DK (NIDDK)
National Institute of Diabetes and Digestive and Kidney Diseases
341 funded awards, $223.5M total, FY2023-FY2025.
NIH SBIR/STTR funding decisions are made by Institutes and Centers based on portfolio priorities, NOFO scope, and program officer judgment. Historical funding patterns do not guarantee future funding.
Technology areas funded by NIDDK
Limitations
- RePORTER includes funded projects only, not unfunded applications.
- Panel sidebar reflects panels that have appeared on funded records, not future assignment.
- FOA-route status reflects verification at the timestamp shown.
Pattern read
NIDDK funded 341 records and $223M, with a broad mix across research tools, small-molecule therapeutics for metabolic disease, devices (particularly for diabetes management and GI applications), and environmental/occupational work tied to obesity and metabolic risk. Median award is $614K. Concentration is low at 4.7%. R44/R43 ratio is around 2:1; STTR participation (R41 at 37) is moderate. NIDDK's portfolio focus has been firm: diabetes, kidney, digestive, and metabolic disease are the canonical fits.